Emerald Mutual Fund Advisers Trust Invests $3.96 Million in Mirion Technologies, Inc. (NYSE:MIR)

Emerald Mutual Fund Advisers Trust purchased a new position in shares of Mirion Technologies, Inc. (NYSE:MIR - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 226,679 shares of the company's stock, valued at approximately $3,956,000. Emerald Mutual Fund Advisers Trust owned about 0.10% of Mirion Technologies as of its most recent SEC filing.

Several other hedge funds also recently modified their holdings of the business. US Bancorp DE raised its stake in Mirion Technologies by 3,248.7% during the 4th quarter. US Bancorp DE now owns 6,262 shares of the company's stock valued at $109,000 after purchasing an additional 6,075 shares during the last quarter. Tower Research Capital LLC TRC increased its holdings in shares of Mirion Technologies by 162.9% during the 4th quarter. Tower Research Capital LLC TRC now owns 6,649 shares of the company's stock worth $116,000 after purchasing an additional 4,120 shares during the period. Harvest Fund Management Co. Ltd acquired a new position in shares of Mirion Technologies during the fourth quarter valued at about $120,000. KBC Group NV lifted its stake in shares of Mirion Technologies by 39.2% in the fourth quarter. KBC Group NV now owns 8,002 shares of the company's stock valued at $140,000 after buying an additional 2,254 shares during the period. Finally, SkyView Investment Advisors LLC acquired a new stake in Mirion Technologies during the third quarter worth about $111,000. 78.51% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have issued reports on MIR. Robert W. Baird lowered their price target on shares of Mirion Technologies from $22.00 to $20.00 and set an "outperform" rating on the stock in a report on Friday, April 4th. B. Riley dropped their price target on shares of Mirion Technologies from $19.00 to $17.00 and set a "buy" rating for the company in a research report on Wednesday, April 16th. Finally, Citigroup decreased their price objective on Mirion Technologies from $20.00 to $17.00 and set a "buy" rating on the stock in a report on Monday, April 14th. Four analysts have rated the stock with a buy rating and one has issued a strong buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Buy" and an average price target of $18.75.

Mirion Technologies Price Performance

MIR traded up $0.46 during trading on Friday, hitting $16.21. The company's stock had a trading volume of 1,780,730 shares, compared to its average volume of 1,673,742. The firm's 50 day moving average price is $14.50 and its two-hundred day moving average price is $15.68. The company has a quick ratio of 1.55, a current ratio of 2.16 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $3.77 billion, a price-to-earnings ratio of -85.32 and a beta of 0.75. Mirion Technologies, Inc. has a 12 month low of $9.11 and a 12 month high of $18.81.

Mirion Technologies (NYSE:MIR - Get Free Report) last issued its quarterly earnings results on Tuesday, April 29th. The company reported $0.10 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.08 by $0.02. Mirion Technologies had a negative net margin of 4.21% and a positive return on equity of 4.78%. The business had revenue of $202.00 million for the quarter, compared to the consensus estimate of $199.34 million. During the same quarter in the prior year, the company earned $0.06 EPS. The firm's quarterly revenue was up 4.9% on a year-over-year basis. Sell-side analysts forecast that Mirion Technologies, Inc. will post 0.39 earnings per share for the current fiscal year.

About Mirion Technologies

Mirion Technologies, Inc provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies.